Global Tissue Sectioning Market: Overview
Tissue sectioning is the cutting of tissues into accurate and consistent slices using an instrument called a microtome. It can be done with the help of manual as well as automated tools. With the advancement in automated methods, one can be sliced into ultra-thin sections to dive deep into the cause of underlying disease. It also helps in the demonstration of antigens.
Global Tissue Sectioning Market: Growth Factors
Some of the significant factors like increasing demand for healthcare expenditure, the emerging prevalence of cancer, and digital pathology are boosting the growth of global tissue sectioning market.
Cancer is among the leading causes of death across the world. It is the foremost factor boosting the growth in demand for histopathology examination tests for the diagnosis of cancer-causing malignant tumor. This test involves tissue sectioning pathology examination to analyze biopsy tissue to determine the stage of cancer and its type. Thus, the increment in the adoption rates of these tests propels the global tissue sectioning market growth.
The growing geriatric population across the world and the rapid increase in personalized therapeutics will drive the growth of the global tissue sectioning market over the forecast years.
Personalized treatment is a distinct feature in cancer treatment and it is expanding in various dimensions to benefit patients globally.
Furthermore, advanced hospital care centers with in-house pathology boost the market growth. The recent surge in certified pathologists dealing with cancer cases is anticipated to support market growth over the forecast years. Automated technology is expected to increase the demand of the tissue sectioning market globally due to consistent precision and increased productivity.
Global Tissue Sectioning Market: Segmentation
The global tissue sectioning market can be segmented into product, technology, application, end-use, and region.
By product, the market can be broadly classified into instruments, accessories, consumables, and services. The instruments product segment is dominating the market and is likely to represent larger chunks over the forecast period. The instruments segment is further sub-classified into cryostat, ultramicrotome, and others.
Among the classified instruments segment, the cryostat and microtomes instruments are the leading segments owing to increase in demands of homogenous tissue section process. Microtomes can cut tissue to a thickness of about 0.1 to 100 micrometer. Rotary microtome is likely to grow significantly over the forecast years. The growth can be attributed to the advancements in the automatic microtomes which significantly enhance the productivity and efficiency of lab personnel.
By technology, the market can be segmented into manual, semi-automatic, and automatic.
Of these, the automatic segment holds the largest share in the global tissue sectioning market due to the surge in the demands of advanced technology products in the developed countries.
By applications, the market can be segmented into research and diagnostics. The diagnosis segment is likely to expand with a high CAGR during the forecast years. Histopathology test is the standard method for the examination of various disorders like cancer.
By the end-user, the market can be segmented into research centers, diagnostic labs, clinics, and hospitals. The hospital segment holds the largest market share in the market.
Global Tissue Sectioning Market: Regional analysis
North America holds the largest share in the global tissue sectioning market owing to the increasing investments and advancements in healthcare infrastructure by private and public agencies. The rise in the number of cancer cases in the region also contributes to market growth globally.
Asia Pacific is likely to witness a significant increase in CAGR over the forecast period. The growth can be attributed to the surge in research and development activities, huge targeted population, and high unmet demands for clinical advancements.
Global Tissue Sectioning Market: Competitive Players
Some of the significant leaders in the global tissue sectioning market are Leica Biosystems Nussloch GmbH, Sakura Finetek Europe B.V., LLS ROWIAK LaserLabSolutions GmbH, Thermo Fisher Scientific, AGD Biomedicals (P) Ltd., Danaher Corporation, Boeckeler Instruments, Inc., and SLEE medical GmbH.
Global Tissue Sectioning Market: Regional Segment Analysis
What Reports Provides